The ongoing litigation against Indivior, the manufacturer of Suboxone, has reached a pivotal moment as of July 2025, with new developments that could significantly impact the trajectory of the cases. The lawsuits, consolidated into a federal multidistrict litigation (MDL), allege that sublingual Suboxone strips have caused severe dental issues, including tooth decay, loss, and oral infections. The scientific evidence supporting these claims is becoming increasingly robust, lending credibility to the plaintiffs' allegations.
One of the critical hurdles in the litigation has been the delay in accessing pharmacy records, essential for verifying Suboxone use among plaintiffs. Walgreens, in particular, has come under fire for not complying with the court's 30-day deadline for producing these records, leading to a scheduled hearing to address the issue. Meanwhile, other pharmacies like Safeway and Porch Light Health have successfully resolved their record production challenges.
The plaintiff pool has also seen adjustments, with 48 individuals removed from the initial 500 selected for early-stage discovery due to voluntary dismissals or documentation problems. These spots have been filled through a random selection process, refining the group that will form the basis for the bellwether trial process. This process will see 100 cases moving into deeper discovery, with four advancing to trial, setting a precedent for how similar cases might be handled.
Despite the growing number of affected individuals coming forward, a settlement is not on the immediate horizon. Legal analysts suggest that Indivior may be waiting for the three-year statute of limitations to expire, potentially reducing the number of new claims. Meaningful settlement discussions are now projected for late 2025 or early 2026, leaving plaintiffs in a holding pattern as they await justice.
For those affected by Suboxone-related dental injuries, staying informed is crucial. Lawsuit Legal News continues to serve as a vital resource, offering updates on legal filings, trial movements, and other developments in the litigation. The platform aims to demystify the complex legal process for victims and their families, ensuring they have access to the information needed to navigate their claims.
